ArticleClinicoEconomics and outcomes research : CEOR2019

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab.

Lorie A Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.